AD
Atul Dandekar (CSBO) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $2.9M of MAZE (72,400 sh across 2 lots, as filed), executed Dec 29 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.2M
shares × price, as filed
Last traded
Oct 29
Filed Oct 30
Median ADV $16.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
MAZERecent filings
MAZESALE
Maze Therapeutics, Inc.
View filing →
$341K7,500 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $280K
6,300 sh across 2 lots
Exec Jan 29
Filed Feb 2 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $2.9M
72,400 sh across 2 lots
Exec Dec 29 2025
Filed Dec 31 2025 · 5:30 PM ET